M&As this week: Tiansheng Pharmaceutical Group, Skyline Medical


Pharmaceutical company Tiansheng Pharmaceutical Group Co Ltd plans to acquire 51% stake in medical device company Hubei Xianming Medical Devices Co Ltd for CNY5.1m ($0.76m).

Both the acquirer and target companies are based in China.

"Medical waste management technology provider Skyline Medical Inc has announced plans to merge with CytoBioscience."

Medical waste management technology provider Skyline Medical Inc has announced plans to merge with CytoBioscience, a developer of medical instruments for disease analysis and treatment.

Both the companies involved in the merger are based in the US.